Metraipolis › archive › dc_01d38cafb2cc
Efficacy and safety of obinutuzumab as rescue therapy for rituximab-resistant and rituximab-recurrent primary membranous nephropathy: a retrospective cohort… — Europe PMC PMID:42305641
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42305641
- DOI
- 10.1515/med-2026-1440
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T06:41:56.258Z
- SHA-256 of the archived text
1faf1e23d5a8040bd6b155e3e4f5f220e44759217f6089698b9bf60fd9a8af1c- Stable URL of this page
https://metraipolis.com/documento/dc_01d38cafb2cc
How to cite
Efficacy and safety of obinutuzumab as rescue therapy for rituximab-resistant and rituximab-recurrent primary membranous nephropathy: a retrospective cohort… — Europe PMC PMID:42305641 — Europe PMC (en), https://europepmc.org/article/MED/42305641 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01d38cafb2cc (Metraipolis archive dc_01d38cafb2cc, sha256 1faf1e23d5a8040bd6b155e3e4f5f220e44759217f6089698b9bf60fd9a8af1c)
BibTeX
@misc{dc01d38cafb2cc,
title = {Efficacy and safety of obinutuzumab as rescue therapy for rituximab-resistant and rituximab-recurrent primary membranous nephropathy: a retrospective cohort… — Europe PMC PMID:42305641},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42305641},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01d38cafb2cc; sha256 1faf1e23d5a8040bd6b155e3e4f5f220e44759217f6089698b9bf60fd9a8af1c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42305641. Agents can read the archived copy with the MCP tool read_document.